Effect of Combination Therapy of Endothelin Receptor Antagonist and Phosphodiesterase-5 Inhibitor on Clinical Outcome and Pulmonary Haemodynamics in Patients with Pulmonary Arterial Hypertension: A Meta-Analysis-Reference-Cited by-同舟云学术

Effect of Combination Therapy of Endothelin Receptor Antagonist and Phosphodiesterase-5 Inhibitor on Clinical Outcome and Pulmonary Haemodynamics in Patients with Pulmonary Arterial Hypertension: A Meta-Analysis

Published:2019-08-16 Issue:11 Volume:39 Page:1031-1044
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Kirtania Lopamudra,Maiti Rituparna^ORCID,Srinivasan Anand,Mishra Archana

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s40261-019-00841-1.pdf

Reference51 articles.

1. Bai Y, Sun L, Hu S, Wei Y. Combination therapy in pulmonary arterial hypertension: a meta-analysis. Cardiology. 2011;120(3):157–65.

2. Rivera-Lebron BN, Risbano MG. Ambrisentan: a review of its use in pulmonary arterial hypertension. Ther Adv Respir Dis. 2017;11(6):233–44.

3. Badlam JB, Bull TM. Steps forward in the treatment of pulmonary arterial hypertension: latest developments and clinical opportunities. Ther Adv Chronic Dis. 2017;8(2–3):47–64.

4. Lau EMT, Giannoulatou E, Celermajer DS, Humbert M. Epidemiology and treatment of pulmonary arterial hypertension. Nat Rev Cardiol. 2017;14(10):603–14.

5. Ataya A, Cope J, Alnuaimat H. A review of targeted pulmonary arterial hypertension-specific pharmacotherapy. J Clin Med. 2016;5(12):114.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Therapies in Outpatient Pulmonary Medicine;Medical Clinics of North America;2024-09

2. Pulmonary Hypertension Associated with Anti-synthetase Syndrome: A Case Report and Literature Review;Internal Medicine;2023-12-15

3. Adherence and treatment patterns of disease-specific drugs among patients with pulmonary arterial hypertension: A nationwide, new-user cohort study;Frontiers in Pharmacology;2023-01-12

4. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension;European Heart Journal;2022-08-26

5. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension;European Respiratory Journal;2022-08-25